BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Prognosis
6574 results:

  • 1. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
    Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
    Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
    Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
    Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline biallelic brca2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
    Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
    Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
    Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
    BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of large language models in breast cancer clinical scenarios: a comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2.
    Deng L; Wang T; Yangzhang ; Zhai Z; Tao W; Li J; Zhao Y; Luo S; Xu J
    Int J Surg; 2024 Apr; 110(4):1941-1950. PubMed ID: 38668655
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of Pregnancy on breast cancer Features and prognosis.
    Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
    Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
    Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
    J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
    Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
    [No Abstract]    [Full Text] [Related]  

  • 10. Postpartum breast cancer and Survival in Women With Germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical relevance of glycosylation in triple negative breast cancer: a review.
    Chakraborty M; Kaur J; Gunjan ; Kathpalia M; Kaur N
    Glycoconj J; 2024 Apr; 41(2):79-91. PubMed ID: 38634956
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. PFDN4 as a Prognostic Marker Was Associated with Chemotherapy Resistance through CREBP1/AURKA Pathway in Triple-Negative breast cancer.
    Wang SH; Yeh CH; Wu CW; Hsu CY; Tsai EM; Hung CM; Wang YW; Hsieh TH
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612711
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
    Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
    Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
    Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
    Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Significance of Estrogen/Progesterone Receptor Expression in Metaplastic breast Carcinoma.
    Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
    Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Insights into breast cancer Knowledge Among Female Adolescents in Delta State, Nigeria: A School-Based Study.
    Akpo MO; Akpo EE; Akpo DO
    West Afr J Med; 2024 Feb; 41(2):197-201. PubMed ID: 38583066
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates breast Tumor Metastasis.
    Xu J; Zhou Y; He S; Wang Y; Ma J; Li C; Liu Z; Zhou X
    Drug Metab Dispos; 2024 Apr; 52(5):408-421. PubMed ID: 38575184
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis.
    Zhang S; Cheng T
    Ann Med; 2024 Dec; 56(1):2337729. PubMed ID: 38569199
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
    Salaün H; Djerroudi L; Haik L; Schnitzler A; Bataillon G; Deniziaut G; Bièche I; Vincent-Salomon A; Debled M; Cottu P
    J Pathol Clin Res; 2024 May; 10(3):e12372. PubMed ID: 38563252
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
    Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
    PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 329.